+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

World Histone Deacetylase Inhibitors Market - Opportunities and Forecasts, 2017 - 2023

  • ID: 3773064
  • Report
  • Region: Global
  • Allied Analytics LLP
1 of 2
The Histone deactylase inhibitor (HDAC) is a molecule that consists of different compounds that form a group of anticancer agents. The parent epigenetic market of HDAC is expected to grow at a CAGR of around 30% worldwide from 2013 to 2020. The factors driving this market are increase in cancer incidences, ongoing research and development for the treatment of cancer, other diseases, and the need to improve the effectiveness of new therapies. The major limitation of this market is reimbursement and uncertainty issues. The opportunities for this market are increase in collaborations and huge investments in manufacturing which will ensure significant growth.

Key market players of this market are, Celgene, Acetylon Pharmaceuticals, Celleron Therapeutics, Envivo Pharmaceuticals, Novartis, Merck & Co., and Pfizer.

KEY BENEFITS:

The report provides Market attractiveness analysis for the most attractive geographical region worldwide, and considers factors responsible for rapid growth in the regions.
Various economic factors which are significant in determining market trend, buying decisions and market attractiveness are been analyzed for market estimation and forecasting
The report evaluates the key factors of drivers, restraints and opportunities enabling strategic decision making with perceptive to identify potential market.
The study also discusses various environmental and regulatory factors critical for the market growth.
The analysis will support stakeholders such as manufacturers and distributors in identifying and capturing markets with high potential.

KEY MARKET SEGMENTS

GLOBAL MARKET BY, CLASS

Class I HDACs
Class II HDACs
Class III HDACs

GLOBAL MARKET BY, APPLICATIONS

Cancer
Central Nervous System Disorders
Other Diseases

GLOBAL MARKET BY, GEOGRAPHY

Europe
North America
Asia - Pacific
RoW

KEY AUDIENCES:

Health care centers
Research facilities
Academic institutes
Pharmaceutical companies



* This report will be delivered in 12 Business Days. *
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll